Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Castration-resistant Prostate Cancer × Radium-223 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 16 Neoplasm Metastasis 2 Prostatic Neoplasms, Castration-Resistant 1 Pain 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Metastatic Castration-resistant Prostate Cancer 1 Fatigue 1 Castration-resistant Prostate Cancer 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1

Interventions

enzalutamide 4 Radiotherapy 2 Metastasectomy 2 radium Ra 223 dichloride 1 pembrolizumab 1 disitamab vedotin 1 dactolisib 1 abiraterone 1 VT-464 1 Radium-223 1 Radiosurgery 1 NVP-BKM120 1 Ketoconazole 1 Hydrocortisone 1 Flutamide 1 Cyclophosphamide 1 Crizotinib 1 Control Groups 1 Carboplatin 1 Calcitriol 1 Blood Specimen Collection 1 Albumin-Bound Paclitaxel 1 Abiraterone Acetate 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03305224 2021-09-09

CORE-OCU

Osaka City University

Phase 2 Unknown

Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡